MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
19.90
-0.09 (-0.45%)
At close: Jun 26, 2026, 4:00 PM EDT
20.25
+0.35 (1.76%)
After-hours: Jun 26, 2026, 7:46 PM EDT

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $1.46 billion. The enterprise value is $1.21 billion.

Market Cap 1.46B
Enterprise Value 1.21B

Important Dates

The next estimated earnings date is Tuesday, August 4, 2026, before market open.

Earnings Date Aug 4, 2026
Ex-Dividend Date n/a

Share Statistics

MLTX has 73.62 million shares outstanding. The number of shares has increased by 5.48% in one year.

Current Share Class 73.62M
Shares Outstanding 73.62M
Shares Change (YoY) +5.48%
Shares Change (QoQ) +4.86%
Owned by Insiders (%) 9.37%
Owned by Institutions (%) 50.82%
Float 39.88M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 17,523.28
PB Ratio 5.65
P/TBV Ratio 5.77
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.60, with a Debt / Equity ratio of 0.40.

Current Ratio 8.60
Quick Ratio 7.89
Debt / Equity 0.40
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -28.15

Financial Efficiency

Return on equity (ROE) is -77.85% and return on invested capital (ROIC) is -39.65%.

Return on Equity (ROE) -77.85%
Return on Assets (ROA) -36.66%
Return on Invested Capital (ROIC) -39.65%
Return on Capital Employed (ROCE) -75.47%
Weighted Average Cost of Capital (WACC) 9.79%
Revenue Per Employee n/a
Profits Per Employee -$1.98M
Employee Count 130
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, MLTX has paid $1.08 million in taxes.

Income Tax 1.08M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -57.99% in the last 52 weeks. The beta is 1.04, so MLTX's price volatility has been similar to the market average.

Beta (5Y) 1.04
52-Week Price Change -57.99%
50-Day Moving Average 18.11
200-Day Moving Average 17.85
Relative Strength Index (RSI) 56.06
Average Volume (20 Days) 1,284,726

Short Selling Information

The latest short interest is 5.57 million, so 7.56% of the outstanding shares have been sold short.

Short Interest 5.57M
Short Previous Month 5.47M
Short % of Shares Out 7.56%
Short % of Float 13.96%
Short Ratio (days to cover) 5.92

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -267.37M
Pretax Income -258.39M
Net Income -257.08M
EBITDA -264.29M
EBIT -267.37M
Earnings Per Share (EPS) -$3.87
Full Income Statement

Balance Sheet

The company has $357.92 million in cash and $100.80 million in debt, giving a net cash position of $257.12 million or $3.49 per share.

Cash & Cash Equivalents 357.92M
Total Debt 100.80M
Net Cash 257.12M
Net Cash Per Share $3.49
Equity (Book Value) 254.02M
Book Value Per Share 3.52
Working Capital 350.53M
Full Balance Sheet

Cash Flow

Operating Cash Flow -224.15M
Capital Expenditures n/a
Depreciation & Amortization 3.08M
Net Borrowing 24.47M
Free Cash Flow -224.15M
FCF Per Share -$3.04
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.48%
Shareholder Yield -5.48%
Earnings Yield -17.55%
FCF Yield -15.30%

Analyst Forecast

The average price target for MLTX is $27.62, which is 38.79% higher than the current price. The consensus rating is "Buy".

Price Target $27.62
Price Target Difference 38.79%
Analyst Consensus Buy
Analyst Count 15
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1